MedTrace Logo

Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma Treatment

NCT02601898 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2016-01-08

No results posted yet for this study

Summary

The aim of this study was to compare the therapeutic efficacy of lipoic acid versus progesterone by vaginal administration on subchorionic hematoma resorption in women at the first trimester of pregnancy with threatened miscarriage.

Conditions

  • Subchorionic Hematoma in the First Trimester Pregnancy
  • Miscarriage

Interventions

DEVICE

Lipoic acid

Vaginal capsules (medical device) containing 10 mg of lipoic acid (1 per day)

DRUG

Progesterone

Vaginal capsules (drug) containing 200 mg of progesterone (2 per day)

Sponsors & Collaborators

  • Azienda USL Ferrara

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
24 Years
Max Age
37 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02601898 on ClinicalTrials.gov